9-137163845-C-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM5PP2PP5_Very_Strong
The NM_007327.4(GRIN1):c.2530C>T(p.Arg844Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R844P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_007327.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 8 Pathogenic:4
- -
This sequence change replaces arginine with cysteine at codon 865 of the GRIN1 protein (p.Arg865Cys), in exon 19. The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is not present in population databases (Genome Aggregation Database). This variant has been previously reported in the literature related to the same phenotype as our patient (PMID: 27164704, 30776697, 30945278) and at the time ClinVar contains an entry with 8 pathogenic or likely pathogenic submissiones (Variation ID: 521354). This variant is also known as NM_007327.4:c.2530C>T;(p.Arg844Cys) in the literature. The variant is located in the Ca2+-calmodulin-binding domain, which is a well-established functional domain of the GRIN1 protein. In silico predictors (SIFT, Mutation Taster) suggest that this variant is likely to be disruptive and causative of disease. Therefore, there is sufficient evidence to classify the p.Arg865Cys variant as pathogenic for autosomal dominant GRIN1-associated neurodevelopmental disorder according to the ACMG guidelines (PS3, PM1, PM2, PP2, PP3, PP4). -
The p.Arg844Cys variant in the GRIN1 gene has been previously reported de novo in 4 individuals with features consistent with GRIN1-associated neurodevelopmental disorder (Lemke et al., 2016; Vanderver et al., 2016; Wang et al., 2019). This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). The GRIN1 gene has fewer missense variants in the general population than expected. A low rate of missense variation may suggest that this gene is intolerant to missense variation. Computational tools predict that the p.Arg844Cys is deleterious; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.Arg844Cys variant as pathogenic for autosomal dominant GRIN1-associated neurodevelopmental disorder based on the information above. [ACMG evidence codes used: PS2_VeryStrong; PM2; PP2; PP3] -
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 844 of the GRIN1 protein (p.Arg844Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with epileptic encephalopathy (PMID: 27159321, 27164704, 30776697). In at least one individual the variant was observed to be de novo. This variant is also known as c.2593C>T (p.Arg865Cys). ClinVar contains an entry for this variant (Variation ID: 521354). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt GRIN1 protein function with a positive predictive value of 95%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on GRIN1 function (PMID: 27164704). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
- -
Published functional studies demonstrate a damaging effect (increased and prolonged calcium influx in cortical neurons) (Furuse et al., 2010); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30776697, 27159321, 27164704, 20345915, 23688147, 30945278, 29124671) -
Intellectual disability, autosomal dominant 8;C4693325:Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
- -
Intellectual disability Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at